Addition of Metronidazole to Prevent SSI with Megan Gorman and Marina Frimer
In this IJGC podcast, Dr. Pedro Ramirez discusses Addition of Metronidazole to Prevent SSI with Megan Gorman and Marina Frimer.
Dr. Marina Frimer is a gynecologic oncologist and physician-scientist whose work bridges clinical innovation and translational research in gynecologic malignancies. As Associate Professor at the Zucker School of Medicine at Hofstra/Northwell and Associate Chief for Research and Academic Development at Northwell Health, she plays a key role in advancing academic and clinical research programs in women’s cancer.
Dr. Frimer’s research focuses on improving surgical and therapeutic outcomes in gynecologic oncology, with a particular emphasis on uterine and endometrial cancers. Her recent publications include a phase II clinical trial investigating niraparib maintenance therapy in uterine serous carcinoma (BMJ Open, 2025), studies on perioperative antibiotic optimization for hysterectomy in gynecologic malignancies (Int J Gynecol Cancer, 2025), and patient-derived organoid models of endometrial cancer (Bio Protoc, 2024).
Dr. Frimer has contributed to influential studies on DNA repair mechanisms, endometrial microbiome, and racial disparities in endometrial cancer. Her work has been published in leading journals such as Gynecologic Oncology, JCO Precision Oncology, and International Journal of Gynecological Cancer, and she has collaborated extensively on multi-institutional and translational research initiatives.
Dr. Frimer is recognized for her leadership in mentoring early-career investigators and promoting clinical trial development within Northwell’s gynecologic oncology research program.
Dr. Megan Gorman is a gynecologic oncologist and Assistant Professor at Thomas Jefferson University Hospital in Philadelphia, PA. Dr. Gorman completed her medical education at the Warren Alpert Medical School of Brown University, her training in obstetrics and gynecology at Stony Brook University Hospital, her fellowship in gynecologic oncology at Zucker School of Medicine at Hofstra/Northwell Long Island Jewish Medical Center. Her recent clinical research in gynecologic malignancies focuses on racial disparities in cancer care, improved surgical outcomes, funding disparities in research, the role of next generation sequencing, novel therapies, end of life care, and hormone replacement in survivorship. She has also collaborated on translational research initiatives including the development of a patient-derived organoid model of endometrial cancers. Dr. Gorman is passionate about resident education, promoting health literacy, and the treatment of HPV-associated malignancies, and recently completed her second medical mission in Salima, Malawi.
Brasil